NCT04753112View on ClinicalTrials.gov

Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

September 8, 2021

Study Completion Date

September 20, 2021

Conditions
Pulmonary Hypertension
Interventions
DRUG

Sacubitril / Valsartan Oral Tablet [Entresto]

Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor

Trial Locations (1)

08916

Germans Trias i Pujol University Hospital, Badalona

All Listed Sponsors
lead

Germans Trias i Pujol Hospital

OTHER

NCT04753112 - Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device | Biotech Hunter | Biotech Hunter